Navigation Links
Alabama Hospitals Compare Infection Prevention Performance Statewide With New Benchmarking Tool
Date:4/29/2008

ence of HAIs. Because infection incidence is measured consistently with the NIM, comparisons among hospitals are a meaningful way to identify best practices and focus resources where they have the highest likelihood of reducing HAIs.

"Knowing that East Alabama Medical Center is among the best in the state for infection prevention performance validates the effort we have put behind patient safety initiatives that have reduced infections across our hospital," said Benja Morgan, infection control and employee health manager of East Alabama Medical Center. "But the real benefit from the benchmarking tool is in knowing how other hospitals perform and sharing knowledge and best practices to ensure continued improvement."

MedMined(TM) services launched the benchmarking tool in February as an additional feature for 46 hospitals in Alabama. The new tool will be discussed in detail at the Alabama Quality Forum, being held today in Birmingham, Ala. in conjunction with the Alabama Hospital Quality Initiative (AHQI) best practice meeting. AHQI is a partnership between MedMined(TM) services, Blue Cross and Blue Shield of Alabama and the Alabama Hospital Association. Members of the Alabama Hospital Association's Quality Task Force as well as Infection Control Professionals from Alabama's Association for Professionals in Infection Control (APIC) group worked for more than a year with MedMined(TM) services to provide input into the design of the benchmarking system.

The benchmarking capability will be rolled out to hospitals across the country that use MedMined(TM) services in a phased approach starting in May, and will become part of the standard package at no additional fee.

"Understanding a true hospital-wide view of HAIs is the first step to improving infection prevention," said Patrick Hymel, M.D., vice president and general manager of Cardinal Health's MedMined(TM) services. "The MedMined(TM) benchmarking tool is a big step forward in allowing best
'/>"/>

SOURCE Cardinal Health, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Cardinal Health Releases New Tool to Combat MRSA Infections in Hospitals
2. Cypher(R) Sirolimus-Eluting Coronary Stent Demonstrates Sustained Clinical Benefits Compared to Bare Metal Stents in Five-Year Randomized Clinical Trial With No Differences in Long-Term Safety
3. Five-Year Data From Taxus II Clinical Trial Highlights Safety and Efficacy of Taxus(R) Stent Compared to Bare-Metal Stent
4. Largest Study to Date Shows Significant Reductions in Risks of Blood Clots and Reintervention With CYPHER(R) Sirolimus-eluting Coronary Stent Compared to Taxus Stent
5. INVEGA(TM) Significantly Reduced Symptoms of Schizophrenia Compared to SEROQUEL(R) in Acutely Ill, Hospitalized Patients
6. Patient Enrollment Complete in First Trial to Compare Physiologic Guidance vs. Angiographic Guidance of Stent Deployment in Patients with Multivessel Disease
7. New Study of Concerta(R) Showed Significant Improvement of ADHD Symptom Management in Adults Compared to Placebo
8. Retrospective Analysis Finds That Initiation of Insulin Glargine in Patients With Type 2 Diabetes was Associated With a Lower Incidence Rate of Myocardial Infarction as Compared With NPH Insulin
9. Pharmions Amrubicin Shows Encouraging Results Compared to Standard of Care in Second Line Treatment of Small Cell Lung Cancer
10. TREANDA Significantly Improves Clinical Outcomes in Patients with Chronic Lymphocytic Leukemia Compared to Chlorambucil
11. Study Shows That Low-Molecular Weight Heparin (LMWH) was Associated with Reduced Hospital Costs of Venous Thromboembolism (VTE) Treatment Compared with Unfractionated Heparin (UFH)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2009)... Hospira, Inc. (NYSE: HSP ), a leading ... the launch of its next-generation 50 mL and 100 ... and now offers a complete size range (50 mL ... product. The launch of the 50 mL and 100 ...
(Date:12/4/2009)... OrthoAccel Technologies, Inc., developers of the ... to enhance orthodontics, announced the availability of a ... Corporation , a leader in professional education for ... course focuses on patient views about orthodontic treatment, ...
(Date:12/4/2009)... WILMINGTON, Del., Dec. 4 AstraZeneca (NYSE: ... Drug Administration (FDA) has approved once-daily SEROQUEL XR® (quetiapine ... antidepressants in adults with Major Depressive Disorder (MDD). SEROQUEL ... by the FDA to treat both major depressive disorder ...
Breaking Medicine Technology:Hospira Expands VisIV(TM) Portfolio to Offer Complete Range of Environmentally Friendly I.V. Containers 2Hospira Expands VisIV(TM) Portfolio to Offer Complete Range of Environmentally Friendly I.V. Containers 3Hospira Expands VisIV(TM) Portfolio to Offer Complete Range of Environmentally Friendly I.V. Containers 4AcceleDent Science is Showcased in New Continuing Education Course Published by PennWell 2AcceleDent Science is Showcased in New Continuing Education Course Published by PennWell 3AcceleDent Science is Showcased in New Continuing Education Course Published by PennWell 4US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 2US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 3US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 4US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 5US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 6US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 7US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 8US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 9U S and European Experts Applaud Creation of New Transatlantic Task Force on Global Antibiotic Resistance Threat 60841 1U S and European Experts Applaud Creation of New Transatlantic Task Force on Global Antibiotic Resistance Threat 60841 2U S and European Experts Applaud Creation of New Transatlantic Task Force on Global Antibiotic Resistance Threat 60841 3U S and European Experts Applaud Creation of New Transatlantic Task Force on Global Antibiotic Resistance Threat 60841 4New Study 3A Life Science Jobs Total 77 000 in Washington State 60836 1New Study 3A Life Science Jobs Total 77 000 in Washington State 60836 2New Study 3A Life Science Jobs Total 77 000 in Washington State 60836 3Good Sleepers More Likely to Eat Right 60832 1
... Feb. 24 Many soldiers who experienced mild head trauma ... are returning to the United States with headaches, according to ... American Academy of Neurology,s 61st Annual Meeting in Seattle, April ... WA, involved 978 U.S. Army soldiers returning from Iraq or ...
... Nash Corporation (Nasdaq: KNSY ) announced today ... application to the U.S. Food and Drug Administration (FDA) ... technology for treating articular cartilage defects of the knee. ... Device, which consists of a proprietary bi-phasic, bioresorbable implant ...
Other Medicine Technology:For Iraq Veterans, Headaches Continue After Traumatic Brain Injury 2Kensey Nash Announces IDE Submission for Cartilage Repair Device 2Kensey Nash Announces IDE Submission for Cartilage Repair Device 3Kensey Nash Announces IDE Submission for Cartilage Repair Device 4
(Date:12/6/2009)... the loss of a key segment of DNA can lead ... show that this kind of genetic alteration can cause obesity. ... The study, led by Dr Sadaf Farooqi from the University ... Sanger Institute, looked at 300 children with severe obesity. , ... of mutation known as copy number variants (CNVs). CNVs are ...
(Date:12/6/2009)... signs of feline DNA in virus , , SUNDAY, Dec. 6 ... AIDS might be found in a tiger that lived thousands ... It appears the virus took on a bit of a ... cat remains in the virus to this day. That tiger, ... evolution of the virus that ultimately led to its infection ...
(Date:12/6/2009)... Dec. 6 Onyx Pharmaceuticals, Inc. (Nasdaq: ... from the pivotal Phase 2b 003-A1 study, known ... well-tolerated in heavily pre-treated relapsed and refractory multiple ... the ASH/ASCO Joint Symposium at the 51st annual ... in New Orleans. Enrollment in this trial is ...
(Date:12/6/2009)... 6 Blood clotting, or coagulation, is ... a blood vessel is injured. Sometimes, however, clots ... obvious injury or do not dissolve naturally, a ... at the 51st Annual Meeting of the American ... using the anticoagulants aspirin and heparin with the ...
(Date:12/6/2009)... and Treatment site www.sleeping-with-a-sleeping-disorder.com is asking ... or natural sleep aids from around the world ... good cause. The submissions will be compiled in ... by YOU, to be sold from the website ... 100% of the proceeds ,from sales of the ...
Breaking Medicine News(10 mins):Health News:Genetic studies reveal new causes of severe obesity in childhood 2Health News:AIDS May Date Back to Ancient Tiger 2Health News:Carfilzomib Safety Data From Ongoing Phase 2b Pivotal Trial in Relapsed and Refractory Multiple Myeloma Show Promising Safety and Tolerability 2Health News:Carfilzomib Safety Data From Ongoing Phase 2b Pivotal Trial in Relapsed and Refractory Multiple Myeloma Show Promising Safety and Tolerability 3Health News:Carfilzomib Safety Data From Ongoing Phase 2b Pivotal Trial in Relapsed and Refractory Multiple Myeloma Show Promising Safety and Tolerability 4Health News:Carfilzomib Safety Data From Ongoing Phase 2b Pivotal Trial in Relapsed and Refractory Multiple Myeloma Show Promising Safety and Tolerability 5Health News:Three Anticoagulant Studies May Change Current Medical Practice Including New Data Revealing That Preventative Use of Aspirin and Heparin is Not Effective in Reducing Recurrent, Unexplained Miscarriages 2Health News:Three Anticoagulant Studies May Change Current Medical Practice Including New Data Revealing That Preventative Use of Aspirin and Heparin is Not Effective in Reducing Recurrent, Unexplained Miscarriages 3Health News:Three Anticoagulant Studies May Change Current Medical Practice Including New Data Revealing That Preventative Use of Aspirin and Heparin is Not Effective in Reducing Recurrent, Unexplained Miscarriages 4Health News:Three Anticoagulant Studies May Change Current Medical Practice Including New Data Revealing That Preventative Use of Aspirin and Heparin is Not Effective in Reducing Recurrent, Unexplained Miscarriages 5Health News:Three Anticoagulant Studies May Change Current Medical Practice Including New Data Revealing That Preventative Use of Aspirin and Heparin is Not Effective in Reducing Recurrent, Unexplained Miscarriages 6Health News:Three Anticoagulant Studies May Change Current Medical Practice Including New Data Revealing That Preventative Use of Aspirin and Heparin is Not Effective in Reducing Recurrent, Unexplained Miscarriages 7Health News:Donate a Herbal Natural Sleep Aid to the Internet's First "Natural Sleep Aids E-book" Written by People Just Like You 2
... effective in treating wet age related macular degeneration disease which ... macular degeneration is caused due to a chronic degenerative disease ... in the retina which is responsible for proper eye sight. ... of abnormal blood vessel beneath the macula which leads to ...
... Professor Timothy Lohman and colleagues from University of Arizona ... post-menopausal women with calcium supplements and regular exercise makes ... in Bone Mineral Density (BMD) which highly reduces the ... ,Osteoporosis mostly occurs in old age people and ...
... in the Indian State of Orissa are facing a social boycott ... have only their uncle to count on for help. // They ... worked in Mumbai as a laborer for nearly 15 years. When ... Gouranga Naik said. Sourendra who was suffering from AIDS passed away ...
... the environment and are thought to cause cancer in ... bags, stain-free carpets, fast-food wrappers, denture cleaners, windshield washer ... of Toronto had led a team which has investigated ... years. These fluorinated polymers degrade and eventually become a ...
... to be unlucky for Biomedical Tissue Services Ltd a ... cadavers. // The Food and Drug Administration ... donor policies that might pose a threat to transplant ... the patients have been diagnosed with any form of ...
... influenza virus has wrecked havoc on schools with sixty of ... virus and flu. // About 20 schools in Birmingham, Sandwell ... children at these schools were suffering from violent vomiting, diarrhoea ... at the Trinity Primary School, in Hereford. Doug Lowe, the ...
Other Medicine News:Health News:PFCAs Detected in the Artic 2Health News:Chicago :FDA imposes Ban on Biomedical Tissue Services 2
The Model 305 is a hand-held, portable, lightweight oximeter designed for spot checking. It has a NiCad rechargeable battery....
... into comfortable holder, measuring switch is ... is performed., ,Large display of ... surroundings, back light automatically turns on ... compact contour and design provide steady, ...
... The FingerPrint Pulse Oximeter is a ... an integral printer. A light-weight, ... and pulse rate measurements, it ... 4 AA alkaline batteries, and has ...
... The Capnocheck Sleep Capnograph/Oximeter was designed with ... provides reliable measurements of CO 2 ... and can be used for sleep screening as ... generation system utilizes Serial Autocorrelation (SAC) digital pulse ...
Medicine Products: